TY - JOUR
T1 - European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus
AU - Hammer, Heinz F.
AU - Fox, Mark R.
AU - Keller, Jutta
AU - Salvatore, Silvia
AU - Basilisco, Guido
AU - Hammer, Johann
AU - Lopetuso, Loris
AU - Benninga, Marc
AU - Borrelli, Osvaldo
AU - Dumitrascu, Dan
AU - Hauser, Bruno
AU - Herszenyi, Laszlo
AU - Nakov, Radislav
AU - Pohl, Daniel
AU - Thapar, Nikhil
AU - Sonyi, Marc
AU - European H2-CH4-breath test group
AU - Altorjay, Istvan
AU - Barbara, Giovanni
AU - Baumann-Durchschein, Franziska
AU - Belei, Oana
AU - Churchev, Stanislav
AU - Dominguez-Munoz, Enrique
AU - Effenberger, Maria
AU - Fürst, Stefan
AU - Gasbarrini, Antonio
AU - Götze, Oliver
AU - Haas, Stephan
AU - Hammer, Karin
AU - Krznaric, Zeljko
AU - Leja, Marcis
AU - Mion, Francois
AU - Mulak, Agata
AU - Nakov, Ventsislav
AU - Reinisch, Sieglinde
AU - Shvets, Oleg
AU - Simren, Magnus
AU - Surdea-Blaga, Teodora
AU - Tepes, Bojan
AU - Törnblom, Hans
AU - Tutuian, Radu
AU - Verbeke, Kristin
AU - Vogelsang, Harald
AU - Vranesic-Bender, Darija
AU - Wilder-Smith, Clive
N1 - Funding Information: The guideline was supported by a guideline development grant from UEG. Heinz Hammer and Johann Hammer are shareholders of Carboception GmbH Publisher Copyright: © 2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC. on behalf of United European Gastroenterology.
PY - 2021
Y1 - 2021
N2 - Introduction: Measurement of breath hydrogen (H2) and methane (CH4) excretion after ingestion of test-carbohydrates is used for different diagnostic purposes. There is a lack of standardization among centers performing these tests and this, together with recent technical developments and evidence from clinical studies, highlight the need for a European guideline. Methods: This consensus-based clinical practice guideline defines the clinical indications, performance, and interpretation of H2-CH4-breath tests in adult and pediatric patients. A balance between scientific evidence and clinical experience was achieved by a Delphi consensus that involved 44 experts from 18 European countries. Eighty eight statements and recommendations were drafted based on a review of the literature. Consensus (≥80% agreement) was reached for 82. Quality of evidence was evaluated using validated criteria. Results: The guideline incorporates new insights into the role of symptom assessment to diagnose carbohydrate (e.g., lactose) intolerances and recommends that breath tests for carbohydrate malabsorption require additional validated concurrent symptom evaluation to establish carbohydrate intolerance. Regarding the use of breath tests for the evaluation of oro-cecal transit time and suspected small bowel bacterial overgrowth, this guideline highlights confounding factors associated with the interpretation of H2-CH4-breath tests in these indications and recommends approaches to mitigate these issues. Conclusion: This clinical practice guideline should facilitate pan-European harmonization of diagnostic approaches to symptoms and disorders, which are very common in specialist and primary care gastroenterology practice, both in adult and pediatric patients. In addition, it identifies areas of future research needs to clarify diagnostic and therapeutic approaches.
AB - Introduction: Measurement of breath hydrogen (H2) and methane (CH4) excretion after ingestion of test-carbohydrates is used for different diagnostic purposes. There is a lack of standardization among centers performing these tests and this, together with recent technical developments and evidence from clinical studies, highlight the need for a European guideline. Methods: This consensus-based clinical practice guideline defines the clinical indications, performance, and interpretation of H2-CH4-breath tests in adult and pediatric patients. A balance between scientific evidence and clinical experience was achieved by a Delphi consensus that involved 44 experts from 18 European countries. Eighty eight statements and recommendations were drafted based on a review of the literature. Consensus (≥80% agreement) was reached for 82. Quality of evidence was evaluated using validated criteria. Results: The guideline incorporates new insights into the role of symptom assessment to diagnose carbohydrate (e.g., lactose) intolerances and recommends that breath tests for carbohydrate malabsorption require additional validated concurrent symptom evaluation to establish carbohydrate intolerance. Regarding the use of breath tests for the evaluation of oro-cecal transit time and suspected small bowel bacterial overgrowth, this guideline highlights confounding factors associated with the interpretation of H2-CH4-breath tests in these indications and recommends approaches to mitigate these issues. Conclusion: This clinical practice guideline should facilitate pan-European harmonization of diagnostic approaches to symptoms and disorders, which are very common in specialist and primary care gastroenterology practice, both in adult and pediatric patients. In addition, it identifies areas of future research needs to clarify diagnostic and therapeutic approaches.
KW - fructose
KW - intolerance
KW - lactose
KW - malabsorption
KW - oro-cecal transit time
KW - small intestinal bacterial overgrowth
UR - http://www.scopus.com/inward/record.url?scp=85113678452&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/ueg2.12133
DO - https://doi.org/10.1002/ueg2.12133
M3 - Review article
C2 - 34431620
SN - 2050-6406
JO - United European gastroenterology journal
JF - United European gastroenterology journal
ER -